The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial

References

• Centers for Disease Control and Prevention (CDC). CDC behavioral risk factor surveillance system (BRFSS), 2013, 2014, 2016, 2018, 2020; 2022 [accessed 2022 Dec 12]. https://www.cdc.gov/sleep/data-and-statistics/adults.html.
   Google Scholar
• Fortier-Brochu É, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16(1):83–94. doi:10.1016/J.SMRV.2011.03.008.
   PubMed Web of Science ®Google Scholar
• Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1-3):10–9. doi:10.1016/J.JAD.2011.01.011.
   PubMed Web of Science ®Google Scholar
• Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med. 2009;10(4):427–38. doi:10.1016/J.SLEEP.2008.04.005.
   PubMed Web of Science ®Google Scholar
• Khan MS, Aouad R. The effects of insomnia and sleep loss on cardiovascular disease. Sleep Med Clin. 2017;12(2):167–77. doi:10.1016/J.JSMC.2017.01.005.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association Publishing; 2022:354–357. doi:10.1176/APPI.BOOKS.9780890425787.
   Google Scholar
• Buysse DJ. Insomnia. JAMA. 2013;309(7):706–16. doi:10.1001/JAMA.2013.193.
   PubMed Web of Science ®Google Scholar
• Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18(3):249–55. doi:10.1097/01.YCO.0000165594.60434.84.
   PubMed Web of Science ®Google Scholar
• Gooneratne NS. Complimentary and alternative medicine for sleep disturbances in older adults. Clin Geriatr Med. 2008;24(1):121–38, viii. doi:10.1016/J.CGER.2007.08.002.
   PubMed Web of Science ®Google Scholar
• Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022;269(1):205–16. doi:10.1007/S00415-020-10381-W.
   PubMed Web of Science ®Google Scholar
• Costello RB, Lentino CV, Boyd CC, O’Connell ML, Crawford CC, Sprengel ML, Deuster PA. The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J. 2014;13(1):1–17. doi:10.1186/1475-2891-13-106.
   PubMedGoogle Scholar
• Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. 2017;34:10–22. doi:10.1016/J.SMRV.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Auger RR, Burgess HJ, Emens JS, Deriy L v, Thomas SM, Sharkey KM. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD). An update for 2015: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2015;11(10):1199–236. doi:10.5664/JCSM.5100.
   PubMed Web of Science ®Google Scholar
• Low TL, Choo FN, Tan SM. The efficacy of melatonin and melatonin agonists in insomnia - an umbrella review. J Psychiatr Res. 2020;121:10–23. doi:10.1016/J.JPSYCHIRES.2019.10.022.
   PubMed Web of Science ®Google Scholar
• Bueno APR, Savi FM, Alves IA, Bandeira VAC. Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review. Arq Neuropsiquiatr. 2021;79(8):732–42. doi:10.1590/0004-282X-ANP-2020-0379.
   PubMed Web of Science ®Google Scholar
• Choi S, Huang BC, Gamaldo CE. Therapeutic uses of cannabis on sleep disorders and related conditions. J Clin Neurophysiol. 2020;37(1):39–49. doi:10.1097/WNP.0000000000000617.
   PubMed Web of Science ®Google Scholar
• Bhagavan C, Kung S, Doppen M, John M, Vakalalabure I, Oldfield K, Braithwaite I, Newton-Howes G. Cannabinoids in the treatment of insomnia disorder: a systematic review and meta-analysis. CNS Drugs. 2020;34(12):1217–28. doi:10.1007/S40263-020-00773-X.
   PubMed Web of Science ®Google Scholar
• Brenan M. 14% of Americans say they use CBD products. Gallup. 2019 Aug 7 [accessed 2022 Dec 12]. https://news.gallup.com/poll/263147/americans-say-cbd-products.aspx.
   Google Scholar
• Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, et al. Cannabidiol: state of the art and new challenges for therapeutic applications. Pharmacol Ther. 2017;175:133–50. doi:10.1016/J.PHARMTHERA.2017.02.041.
   PubMed Web of Science ®Google Scholar
• Schlienz NJ, Scalsky R, Martin EL, Jackson H, Munson J, Strickland JC, Bonn-Miller MO, Loflin M, Vandrey R. A cross-sectional and prospective comparison of medicinal cannabis users and controls on self-reported health. Cannabis Cannabinoid Res. 2021;6(6):548–58. doi:10.1089/CAN.2019.0096.
   PubMedGoogle Scholar
• Rapin L, Gamaoun R, el Hage C, Arboleda MF, Prosk E. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic. J Cannabis Res. 2021;3(1):1–10. doi:10.1186/s42238-021-00078-w.
   PubMedGoogle Scholar
• Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23:18–041. doi:10.7812/TPP/18-041.
   PubMedGoogle Scholar
• Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21(S1):417S–27S. doi:10.1002/j.1552-4604.1981.tb02622.x.
   PubMed Web of Science ®Google Scholar
• Chagas MHN, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM, dos Santos AC, Teixeira AL, Hallak JEC, Crippa JAS. Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. J Psychopharmacol. 2014;28(11):1088–98. doi:10.1177/0269881114550355.
   PubMed Web of Science ®Google Scholar
• Zuardi AW, Guimarães FS, Moreira AC. Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res. 1993;26(2):213–7.
   PubMed Web of Science ®Google Scholar
• Crippa JAdS, Zuardi AW, Garrido GEJ, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JEC, McGuire PK, Filho Busatto G. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29(2):417–26. doi:10.1038/sj.npp.1300340.
   PubMed Web of Science ®Google Scholar
• Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32(11):1053–67. doi:10.1007/S40263-018-0578-5.
   PubMed Web of Science ®Google Scholar
• Chesney E, Oliver D, Green A, Sovi S, Wilson J, Englund A, Freeman TP, McGuire P. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology. 2020;45(11):1799–806. doi:10.1038/S41386-020-0667-2.
   PubMed Web of Science ®Google Scholar
• Zuardi A, Crippa J, Dursun S, Morais S, Vilela J, Sanches R, Hallak J. Cannabidiol was ineffective for manic episode of bipolar affective disorder. J Psychopharmacol. 2010;24(1):135–7. doi:10.1177/0269881108096521.
   PubMed Web of Science ®Google Scholar
• Chan T. Best CBD for sleep 2022: top reviews of CBD oils, tinctures, gummies. Rolling Stone. 2022 Nov 3 [accessed 2022 Dec 12]. https://www.rollingstone.com/product-recommendations/lifestyle/best-cbd-for-sleep-1139587/.
   Google Scholar
• Peachman R. Does CBD help with insomnia? The New York Times. 2022 Aug 30 [accessed 2022 Dec 12]. https://www.nytimes.com/2022/08/30/well/live/does-cbd-help-with-insomnia.html.
   Google Scholar
• Juna. CBD oil vs melatonin. Juna Blog. 2022 [accessed 2022 Dec 12]. https://juna-world.com/blogs/news/can-you-take-cbd-oil-melatonin-together-safely.
   Google Scholar
• Botanika Life. CBD vs. melatonin for sleep. Botanika Life Blog. 2022 Oct 20 [accessed 2022 Dec 12]. https://botanika.life/blogs/news/cbd-versus-melatonin-for-sleep.
   Google Scholar
• Tikva. Can CBD help you sleep? Combining CBD and melatonin. Tikva Blog. 2022 [accessed 2022 Dec 12]. https://tikvahealth.com/blog/cannabis-101/can-cbd-help-you-sleep/.
   Google Scholar
• Livingston M. CBN explained: how this cannabinoid can lead to better sleep. CNET. 2022 Jul 17 [accessed 2022 Dec 12]. https://www.cnet.com/health/sleep/cbn-explained-heres-what-to-know-about-the-cannabinoid-sleep-aid/.
   Google Scholar
• Corroon J. Cannabinol and sleep: separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366–71. doi:10.1089/CAN.2021.0006.
   PubMedGoogle Scholar
• Institute of Medicine (US) Roundtable on Value & Science-Driven Health Care. Learning what works: infrastructure required for comparative effectiveness research: workshop summary. Washington (DC): National Academies Press (US); 2011.
   Google Scholar
• Mushlin AI, Ghomrawi H. Health care reform and the need for comparative-effectiveness research. N Engl J Med. 2010;362(3):e6. doi:10.1056/NEJMp0912651.
   PubMed Web of Science ®Google Scholar
• Patient Centered Outcomes Research Institute (PCORI). About PCORI. 2022 [accessed 2023 Feb 21]. https://www.pcori.org/about/about-pcori.
   Google Scholar
• Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, Silvestrini M. Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs. 2018;78(17):1791–804. doi:10.1007/S40265-018-0992-5.
   PubMed Web of Science ®Google Scholar
• Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Cannabidiol (CBD) use in psychiatric disorders: a systematic review. Neurotoxicology. 2019;74:282–98. doi:10.1016/J.NEURO.2019.08.002.
   PubMed Web of Science ®Google Scholar
• Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(12):995–1010. doi:10.1016/S2215-0366(19)30401-8.
   PubMed Web of Science ®Google Scholar
• Zuardi AW, Rodrigues NP, Silva AL, Bernardo SA, Hallak JEC, Guimarães FS, Crippa JAS. Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life. Front Pharmacol. 2017;8:1–9. doi:10.3389/fphar.2017.00259.
   PubMedGoogle Scholar
• Linares IM, Zuardi AW, Pereira LC, Queiroz RH, Mechoulam R, Guimarães FS, Crippa JA. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry. 2019;41(1):9–14. doi:10.1590/1516-4446-2017-0015.
   PubMed Web of Science ®Google Scholar
• Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS sleep disturbance and sleep-related impairment item banks. Behav Sleep Med. 2011;10(1):6–24. doi:10.1080/15402002.2012.636266.
   PubMed Web of Science ®Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92. doi:10.1097/01.MLR.0000062554.74615.4C.
   PubMed Web of Science ®Google Scholar
• Elmes M. The curious case of CBN & sleep. Project CBD. 2022 Jan 12 [accessed 2022 Dec 13]. https://www.projectcbd.org/medicine/curious-case-cbn-sleep.
   Google Scholar
• Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344–64. doi:10.1111/J.1476-5381.2011.01238.X.
   PubMed Web of Science ®Google Scholar
• Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773. doi:10.1371/journal.pone.0063773.
   PubMed Web of Science ®Google Scholar
• Manson JE, Shufelt CL, Robins JM. The potential for postrandomization confounding in randomized clinical trials. JAMA. 2016;315(21):2273–4. doi:10.1001/JAMA.2016.3676.
   PubMed Web of Science ®Google Scholar
• Spinella TC, Stewart SH, Naugler J, Yakovenko I, Barrett SP. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study. Psychopharmacology (Berl). 2021;238(7):1965–77. doi:10.1007/S00213-021-05823-W.
   PubMed Web of Science ®Google Scholar
• Rios P, Cardoso R, Morra D, Nincic V, Goodarzi Z, Farah B, Harricharan S, Morin CM, Leech J, Straus SE, et al. Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews. Syst Rev. 2019;8(1):281. doi:10.1186/s13643-019-1163-9.
   PubMed Web of Science ®Google Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–7. doi:10.1056/NEJMSB1609216.
   PubMed Web of Science ®Google Scholar
• Graham M, Lucas CJ, Schneider J, Martin JH, Hall W. Translational hurdles with cannabis medicines. Pharmacoepidemiol Drug Saf. 2020;29(10):1325–30. doi:10.1002/PDS.4999.
   PubMed Web of Science ®Google Scholar